Keyphrases
Alliance Network
10%
Anterior Uveitis
16%
Aqueous Humor
8%
Autoinflammatory Diseases
11%
Clinical Characteristics
20%
Clinical Features
12%
Co-infection
12%
Colombia
60%
Colombian Patients
15%
Colombians
44%
Congenital Toxoplasmosis
10%
Disease Epidemiology
14%
Dry Eye
10%
Epidemiology
12%
Epidemiology Study
20%
Etiology
12%
High Prevalence
9%
Human Toxoplasmosis
10%
Immune Response
16%
Immunocompromised Patients
10%
Infectious Uveitis
11%
Inflammation
10%
Intermediate Uveitis
9%
Macular Edema
10%
Meta-analysis
36%
Narrative Review
8%
Non-infectious Uveitis
23%
Ocular Diseases
16%
Ocular Hypertension
10%
Ocular Inflammation
13%
Ocular Involvement
11%
Ocular Manifestations
10%
Ocular Toxoplasmosis
89%
Ophthalmic Manifestations
10%
Ophthalmological
10%
Ophthalmologist
11%
Ophthalmology
11%
Optical Coherence Tomography
9%
Panuveitis
10%
Posterior Uveitis
14%
Retinal Vasculitis
11%
Risk Factors
12%
Scleritis
9%
South America
16%
Systematic Meta-analysis
37%
Toxoplasma
21%
Toxoplasma Gondii (T. gondii)
33%
Toxoplasmosis
33%
Uveitis
98%
Visual Impairment
9%
Medicine and Dentistry
Agents Acting on the Eye
8%
Anterior Chamber of Eyeball
8%
Antiviral Therapy
9%
Autoimmunity
11%
Autoinflammatory Disease
9%
Cataract
6%
Chorioretinitis
9%
Cicatricial Pemphigoid
8%
Clinician
7%
Cohort Effect
19%
Congenital Toxoplasmosis
9%
Cross Sectional Study
8%
Disease Epidemiology
12%
Diseases
38%
Dry Eye
8%
Eye Disease
19%
Eye Inflammation
10%
Glaucoma
7%
Immune Response
7%
Infection
15%
Inflammatory Disorder
12%
Intermediate Uveitis
7%
Iridocyclitis
17%
Iris
8%
Macular Edema
9%
Mesenchymal Stem Cell
8%
Meta-Analysis
30%
Mixed Infection
12%
Moxifloxacin
8%
Multiple Sclerosis
6%
Ocular Hypertension
9%
Ocular Toxoplasmosis
56%
Ophthalmology
7%
Optical Coherence Tomography
13%
Pediatrics
18%
Polymerase Chain Reaction
8%
Prevalence
25%
Public Health
8%
Recurrent Disease
7%
Retinal Vasculitis
11%
Scleritis
10%
Systematic Review
37%
Systemic Disease
6%
Toxoplasma gondii
20%
Toxoplasmosis
31%
Uveitis
100%
Visual Acuity
8%
Visual Impairment
13%
Vitreous
7%
Wharton Jelly
7%